Literature DB >> 168916

Prostaglandins and cyclic AMP in epidermis. Evidence for the independent action of prostaglandins and adrenaline on the adenyl cyclase system of pig and human epidermis, normal and psoriatic.

K Adachi, K Yoshikawa, K M Halprin, V Levine.   

Abstract

Prostaglandins E1 and E2 stimulate cyclic AMP accumulation in pig epidermis and in human epidermis from patients with psoriasis. Prostaglandins A1,A2 and F2alpha are relatively ineffective. The fact that this stimulation is not inhibited by a beta-blocker (propranolol) and that the stimulation by prostaglandin E2 and adrenaline is additive indicates that each drug acts independently on the epidermal adenyl cyclase system. In other words, prostaglandins E1 and E2 act on a site other than the beta-receptor of adenyl cyclase in epidermis. The stimulation by prostaglandins E1 and E2 is not additive; hence they probably act on the same site. Concentrations of prostaglandin E above 3X10(-7) M are effective in causing stimulation. This concentration may be within the physilogical range and the contribution of endogenous prostaglandin levels in the control of intracellular cyclic AMP levels cannot be disregarded.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168916     DOI: 10.1111/j.1365-2133.1975.tb03097.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  No evidence for the mutation of ras gene in psoriatic epidermis.

Authors:  H Takahashi; H Iizuka; M Katagiri
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Stimulation of prostaglandin E adenylate cyclase response in pig epidermis by hydrocortisone.

Authors:  H Koizumi; C Yasui; T Shimizu; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Adenylate cyclase system of human trichilemmoma cell line.

Authors:  M Tsutsui; H Iizuka; A Ohkawara; K Adachi; T Kanzaki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Histaminergic mediation of the response of rat skin to topical fluorides.

Authors:  E J Essman; W B Essman; E Valderrama
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

5.  Electron microscopic cytochemical demonstration of adenyl cyclase activity in psoriatic epidermis.

Authors:  J Søndergaard; S Wadskov; T Kobayasi
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017

6.  The effects of prostaglandins E1 and F2alpha on epidermal growth.

Authors:  C B Bentley-Phillips; H Paulli-Jorgensen; R Marks
Journal:  Arch Dermatol Res       Date:  1977-01-31       Impact factor: 3.017

7.  Influence of intercellular agents on proliferation and gene activity of cultured human skin epithelium cells (NCTC 2544).

Authors:  G Reimer; M Mentzer; K Gottschalk; A Neufahrt
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

8.  Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene.

Authors:  Maria Inês Alvelos; Ângela Francisco; Leonor Gomes; Isabel Paiva; Miguel Melo; Pedro Marques; Susana Gama-de-Sousa; Sofia Carreiro; Telma Quintela; Isabel Gonçalves; Manuel Carlos Lemos
Journal:  Pituitary       Date:  2021-01-12       Impact factor: 4.107

9.  Identification of COL3A1 variants associated with sporadic thoracic aortic dissection: a case-control study.

Authors:  Yanghui Chen; Yang Sun; Zongzhe Li; Chenze Li; Lei Xiao; Jiaqi Dai; Shiyang Li; Hao Liu; Dong Hu; Dongyang Wu; Senlin Hu; Bo Yu; Peng Chen; Ping Xu; Wei Kong; Dao Wen Wang
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

10.  Mutations in sphingolipid metabolism genes are associated with ADHD.

Authors:  Marcela Henriquez-Henriquez; Maria T Acosta; Ariel F Martinez; Jorge I Vélez; Francisco Lopera; David Pineda; Juan D Palacio; Teresa Quiroga; Tilla S Worgall; Richard J Deckelbaum; Claudio Mastronardi; Brooke S G Molina; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Transl Psychiatry       Date:  2020-07-13       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.